Imprimis Pharmaceuticals Sells Pennsylvania Facility and Sinus Assets

Industry Reports
Typography

Imprimis Pharmaceuticals, Inc , an ophthalmology-focused pharmaceutical company, announced it has entered into an agreement to sell its Folcroft, Pennsylvania facility and sinus related assets for $450,000.  

The closing of this transaction is expected to occur on or around July 17, 2017, subject to customary terms and conditions. 

Mark L. Baum, CEO of Imprimis said, "We are committed to focusing on our core growing ophthalmology business.  The markets we serve with proprietary products in ophthalmology, including our cataract surgery portfolio, medications used in post-LASIK surgery care, our Simple Drops glaucoma program we recently launched and the upcoming launches we have planned to serve dry eye disease patients and other markets in ophthalmology should allow us to build a profitable and valuable company."  Baum continued, "In furtherance of this focus, we entered into an agreement to sell our Folcroft facility and exit the sinus space.  We believe this is an important step towards reducing non-strategic overhead expenses and focusing internal resources on strengthening our growing ophthalmology business."

About Imprimis Pharmaceuticals
Imprimis Pharmaceuticals, Inc. is a pharmaceutical company dedicated to producing and dispensing high quality innovative medications in all 50 states.  The company's unique business model increases patient access and affordability to many critical medicines.  Headquartered in San Diego, California, Imprimis owns and operates three production and dispensing facilities located in California, New Jersey and Pennsylvania. For more information about Imprimis, please visit the corporate website at www.ImprimisRx.com. 

Investor Contact:
Andrew Boll
This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.
858-704-4042

Market Movers

Rogers Corporation

NYQ : ROG - 20 Jul, 4:02pm
118.27
+0.39 (+0.33%) After Hours:
Open 117.51 Mktcap 2.14B
High 118.33 52wk Hight 118.33
Low 116.08 52wk Low 51.98
Vol 86814 Avg Vol 128148
Eps 5.33 P/e 35.79
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 20 Jul, 4:03pm
6.67
+0.12 (+1.83%) After Hours:
Open 6.64 Mktcap 97.25B
High 6.69 52wk Hight 6.99
Low 6.62 52wk Low 3.89
Vol 73210 Avg Vol 7.87M
Eps 0.49 P/e 13.90
Currency: USD

Merck & Company, Inc. (new)

NYQ : MRK - 20 Jul, 4:00pm
62.94
+0.32 (+0.51%) After Hours:
Open 62.91 Mktcap 172.15B
High 63.24 52wk Hight 66.80
Low 62.85 52wk Low 57.18
Vol 6.66M Avg Vol 8.90M
Eps 3.85 P/e 40.11
Currency: USD

Johnson & Johnson

NYQ : JNJ - 20 Jul, 4:01pm
136.57
+1.36 (+1.01%) After Hours:
Open 135.73 Mktcap 367.90B
High 137.08 52wk Hight 137.08
Low 135.62 52wk Low 109.32
Vol 1388 Avg Vol 5.60M
Eps 7.17 P/e 22.96
Currency: USD

Pfizer, Inc.

NYQ : PFE - 20 Jul, 4:00pm
33.54
-0.08 (-0.24%) After Hours:
Open 33.47 Mktcap 200.16B
High 33.70 52wk Hight 37.39
Low 33.33 52wk Low 29.83
Vol 1053 Avg Vol 20.61M
Eps 2.55 P/e 28.23
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 20 Jul, 3:59pm
13.90
-0.06 (-0.43%) After Hours:
Open 13.94 Mktcap
High 13.94 52wk Hight 16.29
Low 13.86 52wk Low 12.63
Vol 3822 Avg Vol 6067
Eps P/e
Currency: USD
Sign up via our free email subscription service to receive notifications when new information is available.
captcha